PharmaGroup Holding ApS: Financial statements 2024
CVR: 43581791
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PharmaGroup Holding ApS (CVR 43581791) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 114,444 and a net result of DKK 6,126,742. Equity in the 2024 report amounted to DKK 14,648,599. The solvency ratio was 74.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 114,444
- Profit/Loss
- DKK 6,126,742
- Equity
- DKK 14,648,599
- Total Assets
- DKK 19,546,983
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PharmaGroup Holding ApS has published its interim report for the period September 30, 2022 to December 31, 2023.
As of February 1, 2024, KOA Rådgivning & Regnskab ApS has been appointed auditor of PharmaGroup Holding ApS.
About PharmaGroup Holding ApS
PharmaGroup Holding ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Amar Fakhry Alaa Al Dyen-Ahmad. The company is owned by Amar Fakhry Alaa Al Dyen-Ahmad. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 400,274 and a net result of DKK 6,422,018 compared with DKK 6,126,742 the year before. Equity in the 2025 report amounted to DKK 18,214,868.